Ninevah Therapeutics
bringing novel gene therapies to kidney patients
bringing novel gene therapies to kidney patients
Ninevah Therapeutics is a discovery-stage company focused on bringing novel gene therapies to kidney patients. There are more than 450 rare genetic kidney diseases for which there is no cure. In most cases, patients reach end-stage renal failure and require dialysis and a kidney transplant, which significantly affects their quality of life. We are discovering gene therapies that have the potential to cure these patients.
There is no investment information
No recent news or press coverage available for Ninevah Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.